IndraLab
Statements
reach
"To explore the mechanism underlying downregulation of the USP7 level by TSPY1 and TSPYL5, we treated cells overexpressing TSPY1 and TSPYL5 with a protein biosynthesis inhibitor, cycloheximide (CHX), and observed more obvious degradation of USP7; this effect could be inhibited by MG132 treatment."